Brief: Spyre Therapeutics Announces Pricing Of $275 Million Public Offering Of Common Stock
14/10/2025 02:10
Oct 13 (Reuters) - Spyre Therapeutics Inc SYRE.O: SPYRE THERAPEUTICS ANNOUNCES PRICING OF $275.0 MILLION PUBLIC OFFERING OF COMMON STOCK SPYRE THERAPEUTICS INC - PRICING OF 14.9 MILLION SHARES AT $18.50 PER SHARE Source text: ID:nGNX8fhfNs Further company coverage: SYRE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spyre Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
U.S. STOCKS ON THE MOVE-MYR Group, Spyre Therapeutics, AMD
Spyre Therapeutics slips on $350 mln share sale
Brief: Spyre Therapeutics Announces Pricing Of $350.0 Million Public Offering Of Common Stock